Agios (AGIO) Q4 Earnings & Revenues Fall Short of Estimates

Agios Pharmaceuticals, Inc. (AGIO) reported a loss of $1.72 per share in fourth-quarter 2023, wider than the Zacks Consensus Estimate of a loss of $1.64. In the year-ago quarter, the company posted a loss of 67 cents per share.AGIO reported revenues of $7.1 million, which also missed the Zacks Consensus Estimate of $8 million. In the year-ago quarter, the company recorded revenues of $4.3 million.Quarter in DetailIn the reported quarter, revenues were generated entirely from product revenues of Agios’ only ...